Health Canada - Government of Canada
Skip to left navigationSkip over navigation bars to content
About Health Canada

Stakeholder Feedback via the Progressive Licensing Framework Website

Title:
 

Stakeholder Feedback via the Progressive Licensing Framework Website

Description:
 

Health Canada is committed to the modernization of the drug regulatory system. Our vision is a progressive regulatory framework based on sound science and risk management that supports timely access to promising new pharmaceuticals and biologics. This new framework would also provide for the continuous monitoring and reassessment of potential safety, quality, efficacy and effectiveness concerns, as well as the adequate evaluation of benefits and risks, throughout the product life-cycle. The Progressive Licensing Project wishes to actively engage with stakeholders and the general public on their values and expectations, and the central tenets of a drug licensing framework.

The purpose of this website is to present the Progressive Licensing Framework to Canadians in a clear and organized fashion and to solicit feedback on the content of the site, the direction of the project and the concerns and issues that stakeholders may have regarding the new framework.


Target Audience:
 

General public, industry, academia, health professionals, patient groups, consumer groups, federal/provincial/territorial governments, international regulators.


URL:
 

Stakeholder Feedback via the Progressive Licensing Framework Website


Type(s) of activity:

  • Submissions-Online
Date:
 

Beginning: Apr 01 2007
Closing: Not yet determined


Sponsor:
 

Therapeutic Products Directorate, Health Products and Food Branch, Health Canada


Contact Information:
 

Name: Progressive Licensing Project

Email: progressive_licensing@hc-sc.gc.ca

Mail: Progressive Licensing Project
Holland Cross - Tower B, 5th Floor, Mail Stop 3105A
Ottawa, Ontario
K1A 0K9


Supporting Information:
 

Regulatory Review of Pharmaceuticals, Biologics and Medical Devices: 2005 Annual Summary of Performance

Access to Therapeutic Producs: The Regulatory Process in Canada

National Pharmaceuticals Strategy: Progress Report

Blueprint for Renewal Discussion Document


Last Updated: 2007-04-19 Top